1. Introduction {#s0005}
===============

Heterotopic pregnancy is a rare condition associated with an increased risk of maternal or fetal death \[[@bb0005]\]. Approximately 90% of heterotopic pregnancies are a result of an intra-uterine pregnancy and a co-existing tubal ectopic pregnancy \[[@bb0005]\]. Heterotopic caesarean scar pregnancy (HCSP), where the ectopic pregnancy is implanted into the uterine scar, is extremely rare, with only 24 cases reported in the literature \[[@bb0010], [@bb0015], [@bb0020], [@bb0025], [@bb0030], [@bb0035], [@bb0040], [@bb0045], [@bb0050], [@bb0055], [@bb0060], [@bb0065], [@bb0070], [@bb0075], [@bb0080], [@bb0085], [@bb0090], [@bb0095], [@bb0100], [@bb0105], [@bb0110], [@bb0115], [@bb0120], [@bb0125]\]. Diagnosing HCSP is challenging, as over half of women affected are asymptomatic. However, these presentations are likely to be seen more frequently secondary to increasing rates of both caesarean deliveries and assisted reproductive technologies \[[@bb0130]\]. There is no standardised approach to management of these patients and evidence to guide clinical management stems from case series and individual reports \[[@bb0130]\]. The complexity of management arises from the need to consider the viable intra-uterine gestation in addition to the risk of maternal uterine rupture and life-threatening haemorrhage. Furthermore, caesarean scar pregnancy has been recognised as a precursor to morbidly adherent placenta and is associated with placenta accreta in up to 30% of future pregnancies \[[@bb0135]\].

This article examines research to provide an update on the diagnosis, management and prognosis of HCSP. It also outlines an extremely rare case of emergency surgical management for acute bleeding in a patient with a HCSP. Hospital departmental ethics was waived following written patient consent. A literature review of English publications within the last 20 years was conducted through Ovid MEDLINE and EMBASE databases, using the terms "heterotopic pregnancy" and "c(a)esarean scar pregnancy" or "heterotopic c(a)esarean scar pregnancy", "uterine artery ligation".

2. Case Presentation {#s0010}
====================

We describe a 38-year-old woman, gravida 2 para 1, who presented acutely at 9^+0^ weeks of gestation in a spontaneously conceived pregnancy with heavy vaginal bleeding and signs consistent with hypovolaemic shock. Her obstetric history included one caesarean section for breech presentation three years earlier. Notably, serial ultrasounds between 5 and 8 weeks of gestation in the current pregnancy demonstrated a viable intrauterine pregnancy with a concurrent cystic structure (up to 2 ml volume) in the lower uterine cavity at the site of the caesarean scar. This raised clinical concern for a heterotopic pregnancy with rupture of the non-viable caesarean scar pregnancy. The patient remained unstable despite resuscitation and was consented for an emergency examination under anaesthesia, dilation and curettage, plus or minus a laparotomy, plus or minus a hysterectomy. She expressed a strong desire to preserve the viable intrauterine pregnancy and her uterus.

The patient proceeded immediately to the operating theatre. Repeat bedside ultrasound showed a viable fundal intrauterine pregnancy and lower uterine segment distension, with a large blood clot and ongoing bleeding. An ultrasound-guided suction curettage of the lower segment was performed, with removal of thrombus and products of conception (confirmed on histopathology). Subsequently, a Foley catheter was inserted into the uterus, inflated to 70 ml and placed under traction. Despite this, the patient had persistent bleeding and a decision was made to proceed with a laparotomy. Intra-operatively there was no evidence of uterine scar rupture. Bilateral uterine artery ligation was performed without complication, which led to a significant reduction in the patient\'s vaginal bleeding. The patient required massive transfusion intra-operatively with six units packed red blood cells and four units of fresh frozen plasma and her haemoglobin was 96 g/L at the close of the case.

Post-operatively the patient was admitted to the intensive care unit for monitoring and the Foley catheter was removed on day 3 post-operatively. She had an ultrasound at 9^+4^ weeks of gestation, which showed a single live fetus and a heterogenous area in the lower segment of the uterus measuring 61 × 46 × 45 mm (volume 60 ml) ([Fig. A1](#f0005){ref-type="graphic"}), which was deemed to be consistent with a blood clot. The anterior myometrium was intact throughout its length and there was no free fluid in the pouch of Douglas. The patient was discharged home on day 6 post-operatively and followed up as an outpatient.

Serial ultrasounds between 11 and 20 weeks of gestation demonstrated gradual resolution of the clot at the lower uterine segment to 14x11x5mm (0.4 ml). At 27^+0^ weeks of gestation the patient was found to have a shortened cervix to 20 mm and was commenced on vaginal progesterone. A serial ultrasound at 27^+6^ weeks of gestation demonstrated cervical shortening to 11 mm and the patient was subsequently diagnosed with preterm rupture of membranes. Due to the risk of labour and concern about uterine scar rupture, a decision was made to proceed with an emergency lower-segment caesarean section at 28^+1^ weeks of gestation, following a complete course of antenatal steroids and magnesium sulphate. The caesarean section was uncomplicated; however, the liveborn male infant (1200 g, 56% for gestation) was admitted to the neonatal intensive care unit immediately after birth. The neonate unfortunately died on day 3 of life secondary to extreme prematurity, respiratory distress syndrome and bilateral grade three intraventricular haemorrhages.

Two years later the patient had a spontaneously conceived pregnancy, which was complicated by placenta percreta. She underwent an elective laparotomy, classical caesarean section and total abdominal hysterectomy at 34 weeks of gestation, complicated by a 6000 ml intra-operative haemorrhage. The neonate was born in good condition and admitted to the neonatal high-dependency unit for respiratory support. Post-operatively the patient was admitted to the intensive care unit for supportive care and both mother and baby were discharged home in a good condition on day 11 post-operatively.

3. Literature Review {#s0015}
====================

A review of the literature revealed 24 case reports of HCSP up until January 2020 ([Table 1](#t0005){ref-type="table"}). The reported incidence of caesarean scar pregnancy is significantly higher in pregnancies that occur through assisted reproductive technology (3 in 100) compared with naturally conceived pregnancies (1 in 30,000) \[[@bb0005]\]. Despite this, more than half of the reported HCSP examined in this study were spontaneously conceived (13 cases, 54.2%). All 24 cases were diagnosed by transvaginal ultrasound and the majority were asymptomatic.

The treatment of HCSP is dependent upon the patient\'s desire to preserve the viable intra-uterine pregnancy. When the patient has no desire to retain the intrauterine pregnancy, methods such as systemic or local injection of methotrexate, or dilation and curettage can be used \[[@bb0130]\]. The treatment of HCSP in women wishing to preserve the intra-uterine gestation can be divided into three main categories: conservative management (if the ectopic fetal cardiac activity disappears spontaneously); selective embryo reduction in situ; and surgical removal of ectopic gestational tissue. Twenty-two women with a HCSP had a desire to preserve the intrauterine gestation, 15 of whom underwent ultrasound-guided selective reduction (potassium chloride +/− methotrexate +/− embryo aspiration), while 3 underwent surgical excision and 4 were expectantly managed. These treatment modalities were associated with successful preservation of the intrauterine pregnancy and live birth via caesarean section in 18 cases \[[@bb0010], [@bb0015], [@bb0020], [@bb0025], [@bb0030], [@bb0035], [@bb0040],[@bb0060], [@bb0065], [@bb0070], [@bb0075], [@bb0080], [@bb0085], [@bb0090], [@bb0095], [@bb0100],[@bb0115]\] and vaginal birth after caesarean section in 1 case \[[@bb0120]\]. There is a high prevalence of complications later in pregnancy, including preterm rupture of membranes (2 cases) \[[@bb0010],[@bb0020]\], preterm labour (5 cases) \[[@bb0025], [@bb0030], [@bb0035],[@bb0065],[@bb0075]\] and antepartum haemorrhage (2 cases) \[[@bb0015],[@bb0060]\], as well as massive haemorrhage after the caesarean section (8 cases) \[[@bb0030],[@bb0035],[@bb0060],[@bb0070],[@bb0080], [@bb0085], [@bb0090],[@bb0115]\]. Of the other patients reported, one underwent pregnancy termination for fetal malformation at 12 weeks \[[@bb0045]\], one required hysterectomy to control haemorrhage secondary to selective reduction and embryo aspiration \[[@bb0110]\] and one had a septic miscarriage at 16 weeks \[[@bb0125]\].

4. Discussion {#s0020}
=============

This article outlines a complex case where surgical management was utilised for life-threatening haemorrhage in a patient with a HCSP who wished to preserve the intrauterine pregnancy. To our knowledge, there was only one previously published case report of a HCSP with life-threatening first-trimester bleeding. In this case, the patient required a hysterectomy for uncontrollable haemorrhage following selective embryo reduction and aspiration \[[@bb0110]\]. Therefore, we describe the first case of successful preservation of the intrauterine pregnancy and future fertility in a HCSP with heavy first-trimester bleeding. Ultrasound-guided suction curettage is an effective method for treating first-trimester caesarean scar pregnancy, with a relatively low risk of bleeding requiring blood transfusion or hysterectomy \[[@bb0140]\]. Although it has not previously been described in the literature, we suggest that ultrasound-guided suction curettage may be a management strategy for patients with HCSP, to allow preservation of the intrauterine pregnancy and future fertility. This should be performed in a tertiary unit, by a specialist gynaecologist, with appropriate resources to manage complications. Careful case selection is imperative and the patient should be consented for intervention surrounding massive haemorrhage, including uterine artery ligation, uterine artery embolization and hysterectomy.

Caesarean scar pregnancies with higher gestation or vascularity on doppler ultrasound are reported to have a greater risk of bleeding secondary to suction curettage and it has been suggested that initial uterine artery embolization (UAE) reduces this risk \[[@bb0140],[@bb0145]\]. However, neither UAE nor uterine artery ligation (UAL) have been studied during pregnancy due to the theoretical concern of poor uterine perfusion and adverse fetal outcomes. As such, there is no definitive data regarding the safety of UAL for a concurrent pregnancy. In this case, bilateral UAL to control ongoing vaginal haemorrhage after suction curettage was an effective surgical intervention to control haemorrhage, whilst preserving the uterus. The UAL had no immediate implications for the intrauterine pregnancy and there were no signs of uteroplacental insufficiency, as suggested by the continuation of the pregnancy until 28 weeks of gestation with no signs of fetal growth restriction. We hypothesise that uterine perfusion was maintained through collateral supply via the ovarian and vaginal arteries, or recanalisation of the uterine arteries. In this case, the subsequent neonatal death was attributed to extreme prematurity and, interestingly, 21% of reported HCSP are complicated by preterm labour \[[@bb0025], [@bb0030], [@bb0035],[@bb0065],[@bb0075]\]. However, due to theoretical risk of significant harm to the intrauterine pregnancy, it is imperative UAL is carefully considered and further research regarding the safety of UAL in pregnancy is required.

With increasing global rates of caesarean section and utilisation of assisted reproductive technologies we can expect the incidence of caesarean scar pregnancies to increase. In light of this, clinician awareness regarding the significant risk of morbidly adherent placenta in subsequent pregnancies is required \[[@bb0135]\]. Women who have a caesarean scar pregnancy should be judiciously counselled regarding the implications for future pregnancies, including the risk of morbidly adherent placenta, major intra-operative haemorrhage or hysterectomy at time of repeat caesarean delivery. We recommend a thorough discussion about contraception and timing of subsequent pregnancy prior to discharge. It may be advisable that some women are counselled against future pregnancies, particularly those with other risk factors for morbidly adherent placenta after caesarean section, including a higher number of caesarean sections and high parity \[[@bb0150]\]. Women who do conceive subsequently should receive their pregnancy care at a tertiary centre and their first-trimester ultrasound should be performed by an experienced sonographer and assessed for both caesarean scar pregnancy and placenta accreta.

Management strategies for these complex HCSP cases continue to evolve with an increasing number of cases detailed in the literature. Paramount to any management plan is patient safety, careful counselling and documentation of potential adverse outcomes. Ultrasound-guided surgical management with UAL was successful in managing bleeding and preserving the intra-uterine pregnancy in this case. This provides an example of surgical management that can be applied to carefully selected cases with access to tertiary care in the future. Above all, safe and appropriate follow-up for all patients with HCSP is critical to ensure no significant ongoing morbidity and mortality in both the current pregnancy and any subsequent pregnancies.

Appendix A {#s0050}
==========

Fig. A1Ultrasound post-curettage (at 9^+4^ weeks of gestation) demonstrating a blood clot in the lower segment of the uterus measuring 61 × 46 × 45 mm (volume 60 ml).Fig. A1Table 1All published heterotopic caesarean scar pregnancy case reports.Table 1Author/Year of publicationMaternal ageG/PNo. of previous CSConceptionGA at diagnosisPresenting SymptomsTreatment modalityDetails of treatmentPregnancy outcomeComplicationsSalomon et al. 2003364/11IVF ET6NoSelective reductionKCl injectionLive birth by CS at 36 weeks due to PROMNoJurkovic et al. 20033610/33Spontaneous7NoSelective reductionKCl injectionLive birth by CS at 31 weeks due to vaginal haemorrhageNoYazicioglu et al. 2004232/11Spontaneous6 + 2Vaginal bleedingSelective reductionKCl injectionLive birth by CS at 30 + 3 weeks due to PROMNoHsieh et al. 2004384/22IVF ET (triplets)5NoSelective reductionEmbryo aspirationLive twin birth by CS at 32 weeks due to preterm labourNoWang et al. 2007384/33IVF ET6NoSelective reductionKCl injectionLive birth by CS at 35 weeks due to preterm labourPPH managed by bilateral internal iliac ligationTaskin et al. 2009242/11Spontaneous8 + 4Vaginal bleedingSelective reductionKCl injectionLive birth by CS at 34 weeks due to preterm labourPPHDemirel et al. 2009342/11Spontaneous6 + 5Vaginal bleedingSurgical excisionLaparoscopic excisionLive birth by CS at 38 weeksNoGupta et al. 201037?/44IVF ET6 + 1NoSelective reductionEmbryo aspirationPregnancy termination at 12 weeks due to fetal malformationNoWang et al. 2010313/11IVF ET7Vaginal bleedingSurgical excisionHysteroscopic excisionLive birth by CS at 39 weeksNoDuenas-Garcia and Young 2011345/33Spontaneous5NoPregnancy terminationPregnancy termination by methotrexateNoLitwicka et al. 2011312/11IVF ET6Vaginal bleeding and uterine contractionsSelective reductionKCl and methotrexate injectionLive birth by CS at 36 weeks due to placenta abruptionPPHBai et al. 2012372/11IVF ET7 + 6NoExpectant managementLive birth by CS at 36 + 4 due to preterm labourNoUgurlucan et al. 2012343/11OI6NoSelective reductionKCl injection and embryo aspirationLive birth by CS at 38 weeksPPH managed by bilateral internal iliac artery ligation and subtotal hysterectomyUysal and Uysal 2013293/22Spontaneous8NoSelective reductionKCl injectionLive birth by CS at 35 weeks due to preterm labourNoKim et al. 2014345/22Spontaneous5NoExpectant managementEctopic CSP migrated into lower uterine segment at 8 weeksLive twin delivery at 37 weeks by CSPPH due to placenta accreta requiring excision of anterior lower uterine segment and UALLui et al. 2014362/11OI + intrauterine insemination5Vaginal bleedingSelective reductionEmbryo aspirationLive birth at 37 by CSPPH, managed by UAEYu et al. 2016332/11IVF ET8NoSelective reductionKCl injection at 16 + 4Live birth at 37 + 6 by CSPPH due to ectopic placenta accrete and placenta praeviaVetter et al. 2016294/11Spontaneous5Vaginal bleedingSurgical excisionOpen resectionLive birth at 37 + 1 CSNoCzuczwar et al. 2016331Spontaneous6NoSelective reductionKCl injectionLive birth at 37 by CSNoEftekhariyazdi et al. 2017345/22Spontaneous7Vaginal bleedingNilPregnancy termination with misoprostol then dilation and curettageHaemorrhage, managed by emergency total abdominal hysterectomyMiyague et al. 2018272/11Spontaneous6NoSelective reductionKCl injection and embryo aspirationAttempted laparoscopic dissection, converted to hysterectomy.HaemorrhageYin et al. 2018334/11IVF ET9 + 3NoExpectant managementLive birth by CS at 35 + 6 due to placenta praevia and DFMPPHVikhareva et al. 2018272/11Spontaneous11NoExpectant managementLive birth by NVD at 37 weeks with oxytocin augmentationNoTymon-Rosario et al. 2018405/32Spontaneous11 + 0NoSelective reductionKCl injectionSeptic abortion at 16 weeks, uterine artery ligation and D&CHaemorrhage[^1]
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[^1]: Key: G/P gravity/parity; GA gestational age; CS caesarean section; IVF ET in vitro fertilisation embryo transfer; OI ovulation induction; KCl potassium chloride; PROM preterm rupture of membranes; NVD normal vaginal delivery; DFM decreased fetal movements; UAE uterine artery embolization; UAL uterine artery ligation;PPH post-partum haemorrhage.
